The ambition is to get Precision Medicine off the ground in the UK so it can be adopted nationally, available for every young cancer patient who would otherwise face less effective, more toxic treatment.
Prof Dame Sally Davies has said that the NHS must deliver her “genomic dream” within five years.
To do this, we need the NHS and pharmaceutical companies to now work proactively to move the latest in medical science into clinical practice, and support our ambition to ensure all children and young people diagnosed with cancer in the UK have access to precision medicine through the NHS within the framework of clinical trials by 2020.
You can read more about the potential for precision medicine and our five-point plan setting out what needs to happen to ensure that all children diagnosed with cancer in the UK have access to precision medicine by 2020 here:
Read the online article here: